BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy. 2005;51 Suppl 1:1-22. [PMID: 15855746 DOI: 10.1159/000081988] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Parodi A, Sessarego M, Greco A, Bazzica M, Filaci G, Setti M, Savarino E, Indiveri F, Savarino V, Ghio M. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol. 2008;103:1257-1262. [PMID: 18422815 DOI: 10.1111/j.1572-0241.2007.01758.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
2 De Lisle RC, Roach EA, Norkina O. Eradication of Small Intestinal Bacterial Overgrowth in the Cystic Fibrosis Mouse Reduces Mucus Accumulation: . Journal of Pediatric Gastroenterology and Nutrition 2006;42:46-52. [DOI: 10.1097/01.mpg.0000189322.34582.3e] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
3 Yde J, Larsen HM, Laurberg S, Krogh K, Moeller HB. Chronic diarrhoea following surgery for colon cancer-frequency, causes and treatment options. Int J Colorectal Dis 2018;33:683-94. [PMID: 29589108 DOI: 10.1007/s00384-018-2993-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
4 Merli M, Lucidi C, Di Gregorio V, Giannelli V, Giusto M, Ceccarelli G, Riggio O, Venditti M. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int. 2015;35:362-369. [PMID: 24836902 DOI: 10.1111/liv.12593] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 9.3] [Reference Citation Analysis]
5 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Reference Citation Analysis]
6 Bohm M, Siwiec RM, Wo JM. Diagnosis and management of small intestinal bacterial overgrowth. Nutr Clin Pract. 2013;28:289-299. [PMID: 23614961 DOI: 10.1177/0884533613485882] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
7 Bohm M, Shin A, Teagarden S, Xu H, Gupta A, Siwiec R, Nelson D, Wo JM. Risk Factors Associated With Upper Aerodigestive Tract or Coliform Bacterial Overgrowth of the Small Intestine in Symptomatic Patients. J Clin Gastroenterol 2020;54:150-7. [PMID: 30575635 DOI: 10.1097/MCG.0000000000001150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Schneider ARJ, Klueber S, Posselt H, Funk B, Murzynski L, Caspary WF, Stein J. Application of the Glucose Hydrogen Breath Test for the Detection of Bacterial Overgrowth in Patients with Cystic Fibrosis––A Reliable Method? Dig Dis Sci 2009;54:1730-5. [DOI: 10.1007/s10620-008-0559-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
9 Abu-shanab A, Quigley EM. Diagnosis of small intestinal bacterial overgrowth: the challenges persist! Expert Review of Gastroenterology & Hepatology 2014;3:77-87. [DOI: 10.1586/17474124.3.1.77] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
10 Mendoza E, Crismatt C, Matos R, Sabagh O, Campo M, Cepeda J, Villanueva D. Diagnóstico de proliferación bacteriana intestinal en niños: evidencia experimental para sustentar el empleo de lactulosa en la prueba de hidrógeno y su validación como prueba tamiz. biomedica 2007;27:325. [DOI: 10.7705/biomedica.v27i3.195] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
11 Reddymasu SC, Sostarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol. 2010;10:23. [PMID: 20175924 DOI: 10.1186/1471-230x-10-23] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
12 Kasir R, Zakko S, Zakko P, Adler M, Lee A, Dhingra S, Guttermuth C. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome. Dig Dis Sci 2016;61:846-51. [DOI: 10.1007/s10620-015-3872-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, Magari H, Inoue I, Maekita T, Ueda K, Enomoto S, Iguchi M, Yanaoka K, Tamai H, Akimoto S, Nomoto K, Tanaka R, Ichinose M. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun 2009;381:666-70. [PMID: 19248769 DOI: 10.1016/j.bbrc.2009.02.109] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
14 Frey A, Ramaker K, Röckendorf N, Wollenberg B, Lautenschläger I, Gébel G, Giemsa A, Heine M, Bargheer D, Nielsen P. Fate and Translocation of (Nano)Particulate Matter in the Gastrointestinal Tract. In: Gehr P, Zellner R, editors. Biological Responses to Nanoscale Particles. Cham: Springer International Publishing; 2019. pp. 281-327. [DOI: 10.1007/978-3-030-12461-8_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Lippi G, Danese E, Cervellin G, Montagnana M. Laboratory diagnostics of spontaneous bacterial peritonitis. Clin Chim Acta. 2014;430:164-170. [PMID: 24508989 DOI: 10.1016/j.cca.2014.01.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
16 Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 2007;44:212-8. [PMID: 17255834 DOI: 10.1097/MPG.0b013e31802c0ceb] [Cited by in Crossref: 71] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
17 Hu Y, He LH, Xiao D, Liu GD, Gu YX, Tao XX, Zhang JZ. Bacterial flora concurrent with Helicobacter pylori in the stomach of patients with upper gastrointestinal diseases. World J Gastroenterol 2012; 18(11): 1257-1261 [PMID: 22468090 DOI: 10.3748/wjg.v18.i11.1257] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
18 Lu PJ, Hsu PI, Chen CH, Hsiao M, Chang WC, Tseng HH, Lin KH, Chuah SK, Chen HC. Gastric juice acidity in upper gastrointestinal diseases. World J Gastroenterol 2010; 16(43): 5496-5501 [PMID: 21086570 DOI: 10.3748/wjg.v16.i43.5496] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
19 Hu Y, He LH, Xiao D, Liu GD, Gu YX, Tao XX, Zhang JZ. Bacterial flora concurrent with Helicobacter pylori in the stomach of patients with upper gastrointestinal diseases. World J Gastroenterol. 2012;18:1257-1261. [PMID: 22468090 DOI: 10.374/wjg.v18.i11.1257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan. Saudi J Gastroenterol 2011;17:371-5. [PMID: 22064333 DOI: 10.4103/1319-3767.87176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
21 Losurdo G, Leandro G, Ierardi E, Perri F, Barone M, Principi M, Leo AD. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis. J Neurogastroenterol Motil 2020;26:16-28. [PMID: 31743632 DOI: 10.5056/jnm19113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
22 Wang H, Zhao JX, Hu N, Ren J, Du M, Zhu MJ. Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins. World J Gastroenterol 2012; 18(18): 2180-2187 [PMID: 22611310 DOI: 10.3748/wjg.v18.i18.2180] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 58] [Article Influence: 7.0] [Reference Citation Analysis]
23 Banning M. Bacteria and the gastrointestinal tract: beneficial and harmful effects. Br J Nurs 2006;15:144-9. [PMID: 16493321 DOI: 10.12968/bjon.2006.15.3.20512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
24 Unger MM, Becker A, Keller A, Schäfer KH, Schwiertz A, Oertel WH. [The role of the gut microbiome in idiopathic Parkinson's disease]. Nervenarzt 2020;91:1085-95. [PMID: 33025073 DOI: 10.1007/s00115-020-01011-x] [Reference Citation Analysis]
25 Ghoshal UC, Ghoshal U. Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders. Gastroenterol Clin North Am. 2017;46:103-120. [PMID: 28164845 DOI: 10.1016/j.gtc.2016.09.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
26 De Lisle RC. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2007;293:G104-G111. [PMID: 17363465 DOI: 10.1152/ajpgi.00548.2006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
27 Papastergiou V, Karatapanis S, Georgopoulos SD. Helicobacter pylori and colorectal neoplasia: Is there a causal link? World J Gastroenterol 2016; 22(2): 649-658 [PMID: 26811614 DOI: 10.3748/wjg.v22.i2.649] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
28 De Lisle RC, Roach E, Jansson K. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2007;293:G577-G584. [PMID: 17615175 DOI: 10.1152/ajpgi.00195.2007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
29 Ponziani FR, Gerardi V, Gasbarrini A. Diagnosis and treatment of small intestinal bacterial overgrowth. Expert Rev Gastroenterol Hepatol. 2016;10:215-227. [PMID: 26636484 DOI: 10.1586/17474124.2016.1110017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
30 Waggett BE, McGorum BC, Wernery U, Shaw DJ, Pirie RS. Prevalence of Clostridium perfringens in faeces and ileal contents from grass sickness affected horses: comparisons with 3 control populations. Equine Vet J 2010;42:494-9. [PMID: 20716188 DOI: 10.1111/j.2042-3306.2010.00105.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
31 Shah A, Holtmann G. Clinical Conditions Associated With Bacterial Overgrowth. Gastrointestinal Diseases and their Associated Infections. Elsevier; 2019. pp. 67-83. [DOI: 10.1016/b978-0-323-54843-4.00006-4] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci. 2012;57:1321-1329. [PMID: 22262197 DOI: 10.1007/s10620-012-2033-7] [Cited by in Crossref: 111] [Cited by in F6Publishing: 98] [Article Influence: 12.3] [Reference Citation Analysis]
33 Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med. 2013;5:1465-1483. [PMID: 24039130 DOI: 10.1002/emmm.201201773] [Cited by in Crossref: 171] [Cited by in F6Publishing: 145] [Article Influence: 21.4] [Reference Citation Analysis]
34 La Rosa SL, Casey PG, Hill C, Diep DB, Nes IF, Brede DA. In vivo assessment of growth and virulence gene expression during commensal and pathogenic lifestyles of luxABCDE-tagged Enterococcus faecalis strains in murine gastrointestinal and intravenous infection models. Appl Environ Microbiol 2013;79:3986-97. [PMID: 23603680 DOI: 10.1128/AEM.00831-13] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
35 Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16(24): 2978-2990 [PMID: 20572300 DOI: 10.3748/wjg.v16.i24.2978] [Cited by in CrossRef: 327] [Cited by in F6Publishing: 242] [Article Influence: 29.7] [Reference Citation Analysis]
36 Scarpignato C, Pelosini I. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential. Chemotherapy. 2005;51 Suppl 1:36-66. [PMID: 15855748 DOI: 10.1159/000081990] [Cited by in Crossref: 132] [Cited by in F6Publishing: 128] [Article Influence: 8.3] [Reference Citation Analysis]
37 Coelho LGV, Coelho MCF. Helicobacter pylori and colorectal neoplasms: a concise review. Arq Gastroenterol 2021;58:114-9. [PMID: 33909789 DOI: 10.1590/S0004-2803.202100000-19] [Reference Citation Analysis]
38 Fernandes DC, Jervoise N Andreyev H. Chronic diarrhoea in an oncology patient - Clinical assessment and decision making. Best Pract Res Clin Gastroenterol 2020;48-49:101708. [PMID: 33317791 DOI: 10.1016/j.bpg.2020.101708] [Reference Citation Analysis]
39 Furnari M, Parodi A, Gemignani L, Giannini EG, Marenco S, Savarino E, Assandri L, Fazio V, Bonfanti D, Inferrera S, Savarino V. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010;32:1000-1006. [PMID: 20937045 DOI: 10.1111/j.1365-2036.2010.04436.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
40 Ma G, Shi B, Liu J, Zhang H, YinTao Z, Lou X, Liang D, Hou Y, Wan S, Yang W. Nod2-Rip2 Signaling Contributes to Intestinal Injury Induced by Muramyl Dipeptide Via Oligopeptide Transporter in Rats. Dig Dis Sci 2015;60:3264-70. [PMID: 26138652 DOI: 10.1007/s10620-015-3762-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
41 Bernhard W. Choline in cystic fibrosis: relations to pancreas insufficiency, enterohepatic cycle, PEMT and intestinal microbiota. Eur J Nutr 2021;60:1737-59. [PMID: 32797252 DOI: 10.1007/s00394-020-02358-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Goossens E, Valgaeren BR, Pardon B, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F. Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis. Vet Res 2017;48:9. [PMID: 28209206 DOI: 10.1186/s13567-017-0413-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
43 Rae R, Witte H, Rödelsperger C, Sommer RJ. The importance of being regular: Caenorhabditis elegans and Pristionchus pacificus defecation mutants are hypersusceptible to bacterial pathogens. International Journal for Parasitology 2012;42:747-53. [DOI: 10.1016/j.ijpara.2012.05.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
44 Verrecchia E, Sicignano LL, La Regina M, Nucera G, Patisso I, Cerrito L, Montalto M, Gasbarrini A, Manna R. Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever. Mediators Inflamm 2017;2017:7461426. [PMID: 29379228 DOI: 10.1155/2017/7461426] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Hong KS, Kang SJ, Choi JK, Kim JH, Seo H, Lee S, Jung JW, Kang HR, Cho SH, Kim JS. Gastrointestinal tuberculosis is not associated with proton pump inhibitors: A retrospective cohort study. World J Gastroenterol 2013; 19(2): 258-264 [PMID: 23345949 DOI: 10.3748/wjg.v19.i2.258] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Tham CS, Peh K, Bhat R, Liong M. Probiotic properties of bifidobacteria and lactobacilli isolated from local dairy products. Ann Microbiol 2012;62:1079-87. [DOI: 10.1007/s13213-011-0349-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
47 Sciorsci RL, Piccinno M, Rizzo A. Contractile effect of rifaximin on bovine uterus in the presence of steroid hormone antagonists. Theriogenology 2018;110:74-8. [PMID: 29353143 DOI: 10.1016/j.theriogenology.2017.12.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, Jahn HK, Freudenberg M, Loddenkemper C, Batra A. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One. 2007;2:e662. [PMID: 17653282 DOI: 10.1371/journal.pone.0000662] [Cited by in Crossref: 146] [Cited by in F6Publishing: 146] [Article Influence: 10.4] [Reference Citation Analysis]
49 Scarpellini E, Gabrielli M, Za T, Lauritano EC, Santoliquido A, Rossi E, Ojetti V, Cammarota G, De Stefano V, Gasbarrini A. The interaction between small intestinal bacterial overgrowth and warfarin treatment. Am J Gastroenterol. 2009;104:2364-2365. [PMID: 19727103 DOI: 10.1038/ajg.2009.288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Piccinno M, Rizzo A, Maselli M, Derosa M, Sciorsci R. Modulatory effect of three antibiotics on uterus bovine contractility in vitro and likely therapeutic approaches in reproduction. Theriogenology 2014;82:1287-95. [DOI: 10.1016/j.theriogenology.2014.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
51 Yang I, Nell S, Suerbaum S. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 2013;37:736-61. [DOI: 10.1111/1574-6976.12027] [Cited by in Crossref: 90] [Cited by in F6Publishing: 69] [Article Influence: 11.3] [Reference Citation Analysis]
52 Losurdo G, Salvatore D'Abramo F, Indellicati G, Lillo C, Ierardi E, Di Leo A. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. Int J Mol Sci 2020;21:E3531. [PMID: 32429454 DOI: 10.3390/ijms21103531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
53 Wu HH, Li IJ, Weng CH, Lee CC, Chen YC, Chang MY, Fang JT, Hung CC, Yang CW, Tian YC. Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients. PLoS One. 2013;8:e71532. [PMID: 23936514 DOI: 10.1371/journal.pone.0071532] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
54 Ishida RK, Faintuch J, Paula AM, Risttori CA, Silva SN, Gomes ES, Mattar R, Kuga R, Ribeiro AS, Sakai P, Barbeiro HV, Barbeiro DF, Soriano FG, Cecconello I. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg 2007;17:752-8. [PMID: 17879574 DOI: 10.1007/s11695-007-9139-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
55 Stupak DP, Abdelsayed GG, Soloway GN. Motility disorders of the upper gastrointestinal tract in the intensive care unit: pathophysiology and contemporary management. J Clin Gastroenterol. 2012;46:449-456. [PMID: 22469641 DOI: 10.1097/MCG.0b013e31824e14c1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 3.1] [Reference Citation Analysis]
56 Enko D, Kriegshäuser G. Functional 13C-urea and glucose hydrogen/methane breath tests reveal significant association of small intestinal bacterial overgrowth in individuals with active Helicobacter pylori infection. Clin Biochem 2017;50:46-9. [PMID: 27586816 DOI: 10.1016/j.clinbiochem.2016.08.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
57 Shah A, Morrison M, Burger D, Martin N, Rich J, Jones M, Koloski N, Walker MM, Talley NJ, Holtmann GJ. Systematic review with meta-analysis: The prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther. 2019;49:624-635. [PMID: 30735254 DOI: 10.1111/apt.15133] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
58 Scarpignato C, Pelosini I. Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic. Digestion. 2006;73 Suppl 1:13-27. [PMID: 16498249 DOI: 10.1159/000089776] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 4.9] [Reference Citation Analysis]
59 Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010;24:943-959, viii-ix. [PMID: 20937459 DOI: 10.1016/j.idc.2010.07.007] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
60 Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol. 2006;177:8785-8795. [PMID: 17142781 DOI: 10.4049/jimmunol.177.12.8785] [Cited by in Crossref: 245] [Cited by in F6Publishing: 255] [Article Influence: 17.5] [Reference Citation Analysis]
61 Abis GS, Stockmann HB, van Egmond M, Bonjer HJ, Vandenbroucke-Grauls CM, Oosterling SJ. Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review. J Gastrointest Surg 2013;17:2172-8. [PMID: 24114683 DOI: 10.1007/s11605-013-2379-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
62 Gutierrez IM, Kang KH, Calvert CE, Johnson VM, Zurakowski D, Kamin D, Jaksic T, Duggan C. Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review. J Pediatr Surg 2012;47:1150-4. [PMID: 22703785 DOI: 10.1016/j.jpedsurg.2012.03.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
63 Choudhry MA, Chaudry IH. Alcohol, burn injury, and the intestine. J Emerg Trauma Shock. 2008;1:81-87. [PMID: 19561986 DOI: 10.4103/0974-2700.43187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
64 于佳慧, 王岚峰. 慢性心力衰竭中胃肠系统变化的意义. 世界华人消化杂志 2006; 14(17): 1721-1725 [DOI: 10.11569/wcjd.v14.i17.1721] [Reference Citation Analysis]
65 Morken MH, Nysaeter G, Strand EA, Hausken T, Berstad A. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection. Scandinavian Journal of Gastroenterology 2009;43:141-5. [DOI: 10.1080/00365520701673960] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
66 De Lisle RC, Borowitz D. The cystic fibrosis intestine. Cold Spring Harb Perspect Med. 2013;3:a009753. [PMID: 23788646 DOI: 10.1101/cshperspect.a009753] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 11.9] [Reference Citation Analysis]
67 Tatishchev SF, Vanbeek C, Wang HL. Helicobacter pylori infection and colorectal carcinoma: is there a causal association? J Gastrointest Oncol 2012;3:380-5. [PMID: 23205318 DOI: 10.3978/j.issn.2078-6891.2012.058] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
68 Katiraei P, Bultron G. Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol 2011; 17(23): 2791-2800 [PMID: 21734786 DOI: 10.3748/wjg.v17.i23.2791] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
69 Latella G, Scarpignato C. Rifaximin in the management of colonic diverticular disease. Expert Rev Gastroenterol Hepatol 2009;3:585-98. [PMID: 19929580 DOI: 10.1586/egh.09.63] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
70 De Lisle RC, Meldi L, Flynn M, Jansson K. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine. J Pediatr Gastroenterol Nutr 2008;47:406-16. [PMID: 18852632 DOI: 10.1097/MPG.0b013e31817e0f2c] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
71 Chun HB, Baek IH, Lee MS, Kim JB, Shin SR, Kim BC, Jung SY, Kim JW. Jejunocolic fistula associated with an intestinal T cell lymphoma. Gut Liver. 2011;5:387-390. [PMID: 21927672 DOI: 10.5009/gnl.2011.5.3.387] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
72 Muis MO, Leitao K, Havnen J, Glomsaker TB, Søreide JA. Gastric diverticulum and halitosis-A case for surgery? Int J Surg Case Rep 2014;5:431-3. [PMID: 24907543 DOI: 10.1016/j.ijscr.2014.04.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
73 Parodi A, Dulbecco P, Savarino E, Giannini EG, Bodini G, Corbo M, Isola L, De Conca S, Marabotto E, Savarino V. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol. 2009;43:962-966. [PMID: 19525858 DOI: 10.1097/mcg.0b013e3181a099a5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
74 Mori K, Morisaki H, Yajima S, Suzuki T, Ishikawa A, Nakamura N, Innami Y, Takeda J. Beta-1 blocker improves survival of septic rats through preservation of gut barrier function. Intensive Care Med 2011;37:1849-56. [DOI: 10.1007/s00134-011-2326-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
75 Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther 2008;6:509-21. [PMID: 18662117 DOI: 10.1586/14787210.6.4.509] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
76 Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog. 2010;2:3. [PMID: 20465787 DOI: 10.1186/1757-4749-2-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
77 Owens SR, Greenson JK. The pathology of malabsorption: current concepts. Histopathology. 2007;50:64-82. [PMID: 17204022 DOI: 10.1111/j.1365-2559.2006.02547.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
78 Kerckhoffs AP, Visser MR, Samsom M, van der Rest ME, de Vogel J, Harmsen W, Akkermans LM. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol. 2008;42:1095-1102. [PMID: 18936644 DOI: 10.1097/mcg.0b013e31818474d7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
79 Cook MB, Dawsey SM, Diaw L, Blaser MJ, Perez-Perez GI, Abnet CC, Taylor PR, Albanes D, Virtamo J, Kamangar F. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev. 2010;19:1966-1975. [PMID: 20647397 DOI: 10.1158/1055-9965.epi-10-0270] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
80 Di Palo DM, Garruti G, Di Ciaula A, Molina-Molina E, Shanmugam H, De Angelis M, Portincasa P. Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis. Nutrients 2020;12:E564. [PMID: 32098159 DOI: 10.3390/nu12020564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
81 Gibson PR, Barrett JS. The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Nutrition 2010;26:1038-43. [DOI: 10.1016/j.nut.2010.01.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
82 Friis‐hansen L. Achlorhydria is associated with gastric microbial overgrowth and development of cancer: Lessons learned from the gastrin knockout mouse. Scandinavian Journal of Clinical and Laboratory Investigation 2009;66:607-22. [DOI: 10.1080/00365510600873894] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
83 Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Novi M, Sottili S, Vitale G, Cesario V, Serricchio M, Cammarota G. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008;103:2031-2035. [PMID: 18802998 DOI: 10.1111/j.1572-0241.2008.02030.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
84 Wang P, Yang J, Zhang Y, Zhang L, Gao X, Wang X. Risk Factors for Renal Impairment in Adult Patients With Short Bowel Syndrome. Front Nutr 2020;7:618758. [PMID: 33537339 DOI: 10.3389/fnut.2020.618758] [Reference Citation Analysis]
85 Roccarina D, Lauritano EC, Gabrielli M, Franceschi F, Ojetti V, Gasbarrini A. The role of methane in intestinal diseases. Am J Gastroenterol 2010;105:1250-6. [PMID: 20216536 DOI: 10.1038/ajg.2009.744] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
86 Parodi A, Lauritano E, Nardone G, Fontana L, Savarino V, Gasbarrini A. Small intestinal bacterial overgrowth. Digestive and Liver Disease Supplements 2009;3:44-9. [DOI: 10.1016/s1594-5804(09)60019-x] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
87 Cook MB. Non-acid reflux: the missing link between gastric atrophy and esophageal squamous cell carcinoma? Am J Gastroenterol. 2011;106:1930-1932. [PMID: 22056574 DOI: 10.1038/ajg.2011.288] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
88 Gabrielli M, Sparano L, Roccarina D, Vitale G, Lauritano E, Gasbarrini A. Treatment options for small intestinal bacterial overgrowth. Digestive and Liver Disease Supplements 2009;3:50-3. [DOI: 10.1016/s1594-5804(09)60020-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
89 Andrei M, Nicolaie T, Stoicescu A, Teiușanu A, Gologan Ș, Diculescu M. Intestinal Microbiome, Small Intestinal Bacterial Overgrowth and Inflammatory Bowel Diseases - What are the Connections? Curr Health Sci J 2015;41:197-203. [PMID: 30534422 DOI: 10.12865/CHSJ.41.03.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]